Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine

https://doi.org/10.4081/monaldi.2021.1769

Authors

Abstract

Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a common disorder. From a clinical and immunopathological point of view, different phenotypes and endotypes have been identified. As asthma is frequent comorbidity, biological agents for treating CRSwNP associated with asthma may be an attractive strategy. Biological agents have several mechanisms, such as antagonizing IgE, interleukin (IL) 4, IL-5, and IL-13. However, a workup is mandatory, mainly concerning pheno-endotyping. In this regard, clinical cytological grading (CCG) has been proposed as a useful tool to manage patients with CRSwNP as it allows us to define clinical and immunopathological phenotypes able to identify the ideal candidate for biologics. In particular, the mixed cellular pattern, such as eosinophils and mast cells, could be sensitive to anti-IL-4 agents. There is still a need for well-established indications, criteria of responsiveness, duration, and safety. Moreover, personalized medicine could be opportunely integrated and/or alternated with intranasal corticosteroids to prevent relevant adverse events.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2021-03-08
Info
Issue
Section
Pneumology - Reviews
Keywords:
chronic rhinosinusitis, nasal polyposis, clinical-cytological-grading, biological agents, corticosteroids.
Statistics
  • Abstract views: 190

  • PDF: 113
How to Cite
Ciprandi, Giorgio, and Matteo Gelardi. 2021. “Chronic Rhinosinusitis With Nasal Polyposis: The Role of Personalized and Integrated Medicine”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2021.1769.

Most read articles by the same author(s)